Acne News

• AAD 2022 Synthetic, Botanical Agents Emerging as Promising for Melasma 'None of our patients can be on hydroquinone yearlong, so you have to bring in other agents that are efficacious,' says Dr Nada Elbuluk.
  Medscape Medical News, May 17, 2022
• ASLMS 2022 PIH in Black Patients Responds to Laser Treatment: Case Series The case series included three patients with recalcitrant PIH and Fitzpatrick skin phototypes V and VI treated with a combination of topical and laser therapies.
  Medscape Medical News, May 04, 2022
• Study Provides New Data on Isotretinoin and Psychiatric Effects Although severe neuropsychiatric effects associated with isotretinoin therapy in patients with acne have been reported, 'the evidence base…is mixed and inconclusive,' according to the authors of a new study.
  Medscape Medical News, May 02, 2022
• ASLMS 2022 Safety of Combining Fillers and Lasers Evaluated Over 6 Years Investigators reviewed the charts of 638 patients who had 1186 single-session facial treatments with a laser and a hyaluronic acid filler injection over a 6-year period.
  Medscape Medical News, April 29, 2022
• New Documentary Probes 'the Pill' Use is widespread: 12 million women are currently on the pill, and 80% of women have used it at some point in their life.
  WebMD Health News, April 11, 2022
• AAD 2022 Novel Isotretinoin Ointment for Congenital Ichthyosis Shows Promise TMB-001 is a topical isotretinoin formulation that uses a patented 'IPEG' technology isotretinoin delivery system.
  Medscape Medical News, March 27, 2022
• Acne More Likely in Transgender Patients Receiving Testosterone Transgender patients who receive masculinizing hormone therapy may be more likely to develop acne than cisgender men, cisgender women and transgender patients not receiving testosterone, a new study suggests.
  Reuters Health Information, March 16, 2022
• Injecting Asbestos: Prison Studies Revealed in J&J Talc Lawsuits Revealed during the J&J talc/cancer lawsuits is a study conducted 50 years ago in which prisoners were injected with asbestos. The study was conducted by a prominent dermatologist at the University of Pennsylvannia.
  Medscape Medical News, March 15, 2022
• ODAC 2022 Questions About Optimal Dosing of Isotretinoin Persist Among the questions: What is the ideal daily dose and the ideal duration of isotretinoin therapy?
  Medscape Medical News, March 03, 2022
• Study Links Air Pollution to Psoriasis Flares More studies are needed to determine if the results are applicable to other populations and how air pollution might affect psoriasis disease activity, the investigators write.
  Medscape Medical News, February 24, 2022
• Data Review: Spironolactone Not Linked to Increased Cancer Risk The drug's antiandrogenic properties have driven its off-label use as a treatment for acne, hidradenitis, androgenetic alopecia, and hirsutism, and it is also used in gender-affirming care.
  Medscape Medical News, February 22, 2022
• PCOS Common in Adolescent Girls With Type 2 Diabetes Polycystic ovary syndrome is common in girls with type 2 diabetes, according to the authors of a new study, who say screening for PCOS is critical in this group.
  Medscape Medical News, February 15, 2022
• Increased Diversity Remains Elusive for Dermatological Research "There have not been significant changes in representative inclusion for racial and ethnic minority groups," the investigators concluded.
  Medscape Medical News, February 07, 2022
• More Than a Month After Launch, iPLEDGE Glitches Persist The latest improvement attempt is a tool created by the Isotretinoin Products Manufacturers Group (IPMG), the manufacturers responsible for the FDA-mandated REMS program.
  Medscape Medical News, January 21, 2022
• Dermatologic Use of Medical Cannabis Lags Behind Interest The most common indication among the respondents with dermatologist recommendations for products requiring a medical card was for acne (68%), followed by psoriasis and rosacea (28% each).
  Medscape Medical News, January 20, 2022
• FDA Updates Status of iPLEDGE Access Problems The Isotretinoin Products Manufacturers Group has "created a new tool within the system to help resolve account access for some user groups without using the call center."
  Medscape Medical News, January 14, 2022
• iPLEDGE Rollout: As Frustration Mounts, FDA Agrees to Help At a meeting with the FDA, AADA representatives described the severe impact on patient access to treatment that is resulting from the issues with the iPLEDGE rollout.
  News Alerts, December 22, 2021
• Alert iPLEDGE Rollout Described as a Failure, Chaotic, and a Disaster Dermatologists on Twitter and elsewhere are angry and frustrated, with some calling for a temporary halt to the program until the bugs can be ironed out.
  News Alerts, December 16, 2021
• Dermatologists Take to TikTok to Share Their Own 'Hacks' Millions get skin care advice from TikTok, but it's rarely from board-certified dermatologists.
  Medscape Medical News, December 10, 2021
• Panel Recommends Energy-Based Devices as Treatment of Acne Scars Panel suggests that laser resurfacing does not have to be delayed at least 6 months post isotretinoin in acne patients.
  Medscape Medical News, December 06, 2021